Contraindications to metformin therapy among patients with type 2 diabetes mellitus

[1] Cheng AYY(2003)clinical practice guidelines for the prevention and management of diabetes in Canada Can J Diabetes 27 S1-152

[2] Fantus IG(2005)Oral antihyperglycemic therapy for type 2 diabetes mellitus CMAJ 172 213-26

[3] Kirpichnikov D(1995)Efficacy of metformin in patients with non-insulin dependent diabetes mellitus N Engl J Med 333 541-33

[4] McFarlane SI(2002)Metformin: an update Ann Intern Med 237 25-65

[5] Sowers JR(1998)Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 854-9

[6] Fanghanel G(1996)Metformin’s effects on glucose and lipid metabolism in patients with secondary failure to sulfonylureas Diabetes Care 19 1185-7

[7] Sanchez-Reyes L(1997)Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose–response trial Am J Med 103 491-9

[8] Trujillo C(1993)Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects Diabetes Care 16 621-4

[9] Sotres D(1995)Metabolic effects of metformin in non-insulin dependent diabetes mellitus N Engl J Med 333 550-9

[10] Espinosa-Campos J(1996)Metformin N Engl J Med 334 574-3

[1] Cheng AYY(2003)clinical practice guidelines for the prevention and management of diabetes in Canada Can J Diabetes 27 S1-152

[2] Fantus IG(2005)Oral antihyperglycemic therapy for type 2 diabetes mellitus CMAJ 172 213-26

[3] Kirpichnikov D(1995)Efficacy of metformin in patients with non-insulin dependent diabetes mellitus N Engl J Med 333 541-33

[4] McFarlane SI(2002)Metformin: an update Ann Intern Med 237 25-65

[5] Sowers JR(1998)Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 854-9

[6] Fanghanel G(1996)Metformin’s effects on glucose and lipid metabolism in patients with secondary failure to sulfonylureas Diabetes Care 19 1185-7

[7] Sanchez-Reyes L(1997)Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose–response trial Am J Med 103 491-9

[8] Trujillo C(1993)Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects Diabetes Care 16 621-4

[9] Sotres D(1995)Metabolic effects of metformin in non-insulin dependent diabetes mellitus N Engl J Med 333 550-9

[10] Espinosa-Campos J(1996)Metformin N Engl J Med 334 574-3